GS-1206
/ Gilead
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 11, 2026
A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors
(clinicaltrials.gov)
- P1 | N=302 | Recruiting | Sponsor: Gilead Sciences | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
July 16, 2026
A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors
(clinicaltrials.gov)
- P1 | N=302 | Not yet recruiting | Sponsor: Gilead Sciences
New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1